OrthoPediatrics Corp.
Financials
Valuation Metrics
OrthoPediatrics Corp.'s Market Cap is $560M. At end of 2025 it was $419M. Ranked #2757 of 3,121 in US market (top 88%), #1196 of 1,463 on NASDAQ (top 82%), #168 of 205 in Health Care Equipment & Services (top 82%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $560M | US#2,757/3,121 Sec#168/205 |
| Revenue | $253M | US#2,520/3,121 Sec#163/205 |
| Net Income | $-40M | US—/3,121 Sec—/205 |
| Total Assets | $511M | US#2,763/3,121 Sec#157/205 |
| Net Assets | $344M | US#2,467/3,121 Sec#137/205 |
| Employees | 602 | US#2,195/3,121 Sec#155/205 |
| Value | ||
| P/B | 1.63x | US#990/3,121 Sec#49/205 |
| P/S | 2.22x | US#1,389/3,121 Sec#94/205 |
| FCF Yield | -0.33% | US—/3,121 Sec—/205 |
| Profitability | ||
| ROE | -11.56% | US#2,388/3,121 Sec#138/205 |
| ROA | -7.77% | US#2,614/3,121 Sec#151/205 |
| Op. Margin | -9.01% | US#2,539/3,121 Sec#156/205 |
| Revenue Growth | 14.49% | US#943/3,121 Sec#65/205 |
| Financial Health | ||
| Debt Ratio | 48.83% | US#550/3,121 Sec#62/205 |
| Total Debt | $92M | US#2,467/3,121 Sec#140/205 |
| FCF | $-2M | US#2,335/3,121 Sec#147/205 |
| Cash | $17M | US#2,899/3,121 Sec#190/205 |
| Current Ratio | 4.78x | US#502/3,121 Sec#41/205 |
| Performance | ||
| 1Y Return | 8.50% | US#1,371/3,121 Sec#101/205 |
| 1M Return | -17.66% | US#2,789/3,121 Sec#188/205 |
| From 52W High | -18.40% | US#1,400/3,121 Sec#96/205 |
| 1Y MDD | -27.20% | US#1,207/3,121 Sec#44/205 |
| Trading | ||
| Volume | 300,640 shares | US#2,397/3,121 Sec#168/205 |
| Trading Value | $7M | US#2,539/3,121 Sec#165/205 |
| Per Share | ||
| EPS | $-1.55 | US—/3,121 Sec—/205 |
| BPS | $13.38 | US#1,622/3,121 Sec#91/205 |
Company Info
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.